Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
1(13%)
Results Posted
17%(1 trials)
Terminated
1(13%)

Phase Distribution

Ph not_applicable
7
88%
Ph phase_3
1
13%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution8 total trials
Phase 3Large-scale testing
1(12.5%)
N/ANon-phased studies
7(87.5%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

1

trials recruiting

Total Trials

8

all time

Status Distribution
Active(1)
Completed(6)
Terminated(1)

Detailed Status

Completed6
Active, not recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
1
Success Rate
85.7%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (12.5%)
N/A7 (87.5%)

Trials by Status

active_not_recruiting113%
completed675%
terminated113%

Recent Activity

1 active trials
Showing 5 of 8
active_not_recruitingnot_applicable

Berries, Inflammation, and Gut Microbiome

NCT04100200
completednot_applicable

Effect of Prebiotic FOS on Intestinal Abundance of Faecalibacterium Prausnitzii in Patients With Crohn´s Disease

NCT02539849
completednot_applicable

A Study to Evaluate the Effect of Diet on the Tolerability of FOS in Healthy Volunteers

NCT02628678
terminatedphase_3

Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy

NCT00318474
completednot_applicable

Study to Evaluate the Tolerability of Prebiotics on the Microbiota

NCT02628652
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT04100200Not Applicable

Berries, Inflammation, and Gut Microbiome

Active Not Recruiting
NCT02539849Not Applicable

Effect of Prebiotic FOS on Intestinal Abundance of Faecalibacterium Prausnitzii in Patients With Crohn´s Disease

Completed
NCT02628678Not Applicable

A Study to Evaluate the Effect of Diet on the Tolerability of FOS in Healthy Volunteers

Completed
NCT00318474Phase 3

Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy

Terminated
NCT02628652Not Applicable

Study to Evaluate the Tolerability of Prebiotics on the Microbiota

Completed
NCT02353403Not Applicable

Glycaemic and Insulinaemic Responses After Consumption of FOS.

Completed
NCT02352857Not Applicable

Glycaemic and Insulinaemic Responses After Consumption of FOS.

Completed
NCT00802971Not Applicable

Idiopathic Reactive Hypoglycaemia and Treatment With Fructo-Oligosaccharide

Completed

All 8 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
8